Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovectis is the technology transfer company of Goethe University Frankfurt, dedicated to bridging the gap between academic research and industrial application. Founded in 2000, the company manages the university's intellectual property portfolio, focusing significantly on life sciences, biotechnology, and healthcare innovations. Innovectis facilitates the commercialization of new technologies through patenting, licensing agreements, and the support of high-tech spin-offs. It serves as a central point of contact for industry partners seeking access to cutting-edge research in fields such as oncology, drug delivery, and diagnostics. The company provides professional services to researchers for IP protection and offers industry partners access to innovative technologies and collaborative research opportunities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovectis.